Login Join for free
Popular Searches
Popular news More >
SEARCHING....
no results found
  • Real Time Chart Real Time Chart
  • Stock Profile Stock Profile

  • Financials As Reported

    • accession Number 0000950170-23-017462
    • accounts Payable Current 6,483,000
    • accumulated Depreciation Depletion And Amortization Property Plant And Equipment 7,791,000
    • accumulated Other Comprehensive Income Loss Net Of Tax --3,038,000
    • allocated Share Based Compensation Expense 9,385,000
    • amendment Flag false
    • assets 613,905,000
    • assets Current 411,550,000
    • cash And Cash Equivalents At Carrying Value 50,152,000
    • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect --18,225,000
    • cik 1,815,442
    • city Area Code 857
    • common Stock Par Or Stated Value Per Share 0.0001
    • common Stock Shares Authorized 150,000,000
    • common Stock Shares Issued 55,276,226
    • common Stock Shares Outstanding 55,276,226
    • comprehensive Income Net Of Tax --39,017,000
    • contract With Customer Liability 57,114,000
    • contract With Customer Liability Current 32,248,000
    • current Fiscal Year End Date --12-31
    • date Filed 2023-05-04
    • depreciation 900,000
    • depreciation Depletion And Amortization 879,000
    • document Fiscal Period Focus Q1
    • document Fiscal Year Focus 2,023
    • document Period End Date 2023-03-31
    • document Transition Report false
    • document Type 10-Q
    • earnings Per Share Basic -0.7
    • earnings Per Share Diluted -0.7
    • entity Address Address Line 1 200 Arsenal Yards Blvd
    • entity Address City Or Town Watertown
    • entity Address Postal Zip Code 2,472
    • entity Address State Or Province MA
    • entity Central Index Key 1,815,442
    • entity Current Reporting Status Yes
    • entity Emerging Growth Company false
    • entity File Number 001-39460
    • entity Filer Category Large Accelerated Filer
    • entity Incorporation State Country Code DE
    • entity Interactive Data Current Yes
    • entity Name Kymera Therapeutics, Inc.
    • entity Registrant Name KYMERA THERAPEUTICS, INC.
    • entity Shell Company false
    • entity Small Business false
    • entity Tax Identification Number 81-2992166
    • finance Lease Liability 2,328,000
    • finance Lease Liability Current 1,339,000
    • finance Lease Liability Noncurrent 989,000
    • finance Lease Liability Payments Due 2,558,000
    • finance Lease Liability Payments Due Next Twelve Months 839,000
    • finance Lease Liability Payments Due Year Four 100,000
    • finance Lease Liability Payments Due Year Three 133,000
    • finance Lease Liability Payments Due Year Two 402,000
    • finance Lease Liability Undiscounted Excess Amount 230,000
    • income Tax Expense Benefit 0
    • increase Decrease In Accounts Payable 2,217,000
    • increase Decrease In Contract With Customer Liability --6,145,000
    • interest Paid Net 52,000
    • irs Number 812,992,166
    • lessee Operating Lease Liability Payments Due 118,515,000
    • lessee Operating Lease Liability Payments Due Next Twelve Months 11,482,000
    • lessee Operating Lease Liability Payments Due Year Four 12,881,000
    • lessee Operating Lease Liability Payments Due Year Three 12,506,000
    • lessee Operating Lease Liability Payments Due Year Two 12,142,000
    • lessee Operating Lease Liability Undiscounted Excess Amount 52,086,000
    • liabilities 151,900,000
    • liabilities And Stockholders Equity 613,905,000
    • liabilities Current 61,933,000
    • local Phone Number 285-5300
    • net Cash Provided By Used In Financing Activities 1,159,000
    • net Cash Provided By Used In Investing Activities 24,584,000
    • net Cash Provided By Used In Operating Activities --43,968,000
    • net Income Loss --40,928,000
    • operating Expenses 54,792,000
    • operating Income Loss --45,326,000
    • operating Lease Cost 2,521,000
    • operating Lease Liability 66,429,000
    • operating Lease Liability Current 2,554,000
    • operating Lease Liability Noncurrent 63,875,000
    • operating Lease Right Of Use Asset 56,604,000
    • other Assets Noncurrent 3,155,000
    • other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 1,911,000
    • other Liabilities Current 807,000
    • other Liabilities Noncurrent 237,000
    • other Nonoperating Income Expense 4,398,000
    • payments To Acquire Property Plant And Equipment 4,009,000
    • period End 1,680,220,800,000
    • period Start 1,672,531,200,000
    • property Plant And Equipment Gross 25,223,000
    • property Plant And Equipment Net 17,432,000
    • report Link https://www.sec.gov/Archives/edgar/data/1815442/000095017023017462/kymr-20230331_htm.xml
    • research And Development Expense 42,227,000
    • retained Earnings Accumulated Deficit --424,700,000
    • revenue From Contract With Customer Excluding Assessed Tax 9,466,000
    • share Based Compensation 9,385,000
    • stockholders Equity 462,005,000
    • trading Symbol KYMR
    • update 1970-01-01
    • variable Lease Cost 220,000
    • weighted Average Number Of Diluted Shares Outstanding 58,187,038
    • weighted Average Number Of Shares Outstanding Basic 58,187,038
    • id REPORTED_FINANCIALS
    • key KYMR
    • subkey 10-Q
    • date 2023-05-04
    • updated 2023-05-05
  • Symbol Info Symbol Info
  • Symbol Over View Symbol Over View
  • Technical Analysis Technical Analysis

KYMR stock fundamentals - financials as reported

Financials As Reported

  • accession Number 0000950170-23-017462
  • accounts Payable Current 6,483,000
  • accumulated Depreciation Depletion And Amortization Property Plant And Equipment 7,791,000
  • accumulated Other Comprehensive Income Loss Net Of Tax --3,038,000
  • allocated Share Based Compensation Expense 9,385,000
  • amendment Flag false
  • assets 613,905,000
  • assets Current 411,550,000
  • cash And Cash Equivalents At Carrying Value 50,152,000
  • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect --18,225,000
  • cik 1,815,442
  • city Area Code 857
  • common Stock Par Or Stated Value Per Share 0.0001
  • common Stock Shares Authorized 150,000,000
  • common Stock Shares Issued 55,276,226
  • common Stock Shares Outstanding 55,276,226
  • comprehensive Income Net Of Tax --39,017,000
  • contract With Customer Liability 57,114,000
  • contract With Customer Liability Current 32,248,000
  • current Fiscal Year End Date --12-31
  • date Filed 2023-05-04
  • depreciation 900,000
  • depreciation Depletion And Amortization 879,000
  • document Fiscal Period Focus Q1
  • document Fiscal Year Focus 2,023
  • document Period End Date 2023-03-31
  • document Transition Report false
  • document Type 10-Q
  • earnings Per Share Basic -0.7
  • earnings Per Share Diluted -0.7
  • entity Address Address Line 1 200 Arsenal Yards Blvd
  • entity Address City Or Town Watertown
  • entity Address Postal Zip Code 2,472
  • entity Address State Or Province MA
  • entity Central Index Key 1,815,442
  • entity Current Reporting Status Yes
  • entity Emerging Growth Company false
  • entity File Number 001-39460
  • entity Filer Category Large Accelerated Filer
  • entity Incorporation State Country Code DE
  • entity Interactive Data Current Yes
  • entity Name Kymera Therapeutics, Inc.
  • entity Registrant Name KYMERA THERAPEUTICS, INC.
  • entity Shell Company false
  • entity Small Business false
  • entity Tax Identification Number 81-2992166
  • finance Lease Liability 2,328,000
  • finance Lease Liability Current 1,339,000
  • finance Lease Liability Noncurrent 989,000
  • finance Lease Liability Payments Due 2,558,000
  • finance Lease Liability Payments Due Next Twelve Months 839,000
  • finance Lease Liability Payments Due Year Four 100,000
  • finance Lease Liability Payments Due Year Three 133,000
  • finance Lease Liability Payments Due Year Two 402,000
  • finance Lease Liability Undiscounted Excess Amount 230,000
  • income Tax Expense Benefit 0
  • increase Decrease In Accounts Payable 2,217,000
  • increase Decrease In Contract With Customer Liability --6,145,000
  • interest Paid Net 52,000
  • irs Number 812,992,166
  • lessee Operating Lease Liability Payments Due 118,515,000
  • lessee Operating Lease Liability Payments Due Next Twelve Months 11,482,000
  • lessee Operating Lease Liability Payments Due Year Four 12,881,000
  • lessee Operating Lease Liability Payments Due Year Three 12,506,000
  • lessee Operating Lease Liability Payments Due Year Two 12,142,000
  • lessee Operating Lease Liability Undiscounted Excess Amount 52,086,000
  • liabilities 151,900,000
  • liabilities And Stockholders Equity 613,905,000
  • liabilities Current 61,933,000
  • local Phone Number 285-5300
  • net Cash Provided By Used In Financing Activities 1,159,000
  • net Cash Provided By Used In Investing Activities 24,584,000
  • net Cash Provided By Used In Operating Activities --43,968,000
  • net Income Loss --40,928,000
  • operating Expenses 54,792,000
  • operating Income Loss --45,326,000
  • operating Lease Cost 2,521,000
  • operating Lease Liability 66,429,000
  • operating Lease Liability Current 2,554,000
  • operating Lease Liability Noncurrent 63,875,000
  • operating Lease Right Of Use Asset 56,604,000
  • other Assets Noncurrent 3,155,000
  • other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 1,911,000
  • other Liabilities Current 807,000
  • other Liabilities Noncurrent 237,000
  • other Nonoperating Income Expense 4,398,000
  • payments To Acquire Property Plant And Equipment 4,009,000
  • period End 1,680,220,800,000
  • period Start 1,672,531,200,000
  • property Plant And Equipment Gross 25,223,000
  • property Plant And Equipment Net 17,432,000
  • report Link https://www.sec.gov/Archives/edgar/data/1815442/000095017023017462/kymr-20230331_htm.xml
  • research And Development Expense 42,227,000
  • retained Earnings Accumulated Deficit --424,700,000
  • revenue From Contract With Customer Excluding Assessed Tax 9,466,000
  • share Based Compensation 9,385,000
  • stockholders Equity 462,005,000
  • trading Symbol KYMR
  • update 1970-01-01
  • variable Lease Cost 220,000
  • weighted Average Number Of Diluted Shares Outstanding 58,187,038
  • weighted Average Number Of Shares Outstanding Basic 58,187,038
  • id REPORTED_FINANCIALS
  • key KYMR
  • subkey 10-Q
  • date 2023-05-04
  • updated 2023-05-05

Related News

QQQ ETF ($706.22) Slides 7.4% Below Its High as the Market Reprices the AI Capex Bill — $686.57 Target if $700 Breaks

QQQ ETF ($706.22) Slides 7.4% Below Its High as the Market Reprices the AI Capex Bill — $686.57 Target if $700 Breaks

TradingNEWS Archive 22.10.26
Stocks Markets AMZN MSFT NVDA META
META ($660.00) Swings 12.1% From After-Hours High as Capex Floor Rises to $135B — $600 Target if $648.74 Breaks

META ($660.00) Swings 12.1% From After-Hours High as Capex Floor Rises to $135B — $600 Target if $648.74 Breaks

Itai Smidt 22.10.26
Stocks META PINS SNAP RDDT
S&P 500 7,757, Nasdaq 26,703, Dow 52,856 Face AI Selloff as META, TSLA, LRCX Slide

S&P 500 7,757, Nasdaq 26,703, Dow 52,856 Face AI Selloff as META, TSLA, LRCX Slide

Itai Smidt 22.10.26
Stocks Markets IBM LRCX TSLA META
SMCX ETF ($9.83) Delivers a Clean 2x Day on Super Micro’s Beat — Meta Capex and November 3 Cash Flow Decide $12.88 or $8.13

SMCX ETF ($9.83) Delivers a Clean 2x Day on Super Micro’s Beat — Meta Capex and November 3 Cash Flow Decide $12.88 or $8.13

Itai Smidt 21.10.26
Stocks Markets SMCI MU NVDA AMD
NFLX ($65.69) Trades at 19x Earnings Despite a 34.6% Margin — Path Back to $72.56 Needs Engagement Proof

NFLX ($65.69) Trades at 19x Earnings Despite a 34.6% Margin — Path Back to $72.56 Needs Engagement Proof

Itai Smidt 21.10.26
Stocks NFLX WBD DIS AMZN
TSLA ($386.95) Runs 9% in 4 Sessions on Merger Talk — Q3 Margins Decide $415 or $360

TSLA ($386.95) Runs 9% in 4 Sessions on Merger Talk — Q3 Margins Decide $415 or $360

Itai Smidt 21.10.26
Stocks TSLA GM F TM
Trade Now
© Trading News. All Rights Reserved Since 2022